The serum of rabbits with experimental allergic encephalomyelitis is known to contain substances which produce demyelination in cultures of newborn rat cerebellum (Bornstein and Appel, 1961) . Although the evidence is far from secure, experimental allergic encephalomyelitis is commonly regarded as a " model " for human multiple sclerosis, and serum from patients with this disease has been claimed to possess a similar demyelinating activity (Bornstein, 1963) . The present work reports a high proportion of positive results from serum of cases of motor neurone disease.
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Material and Methods
Cases of motor neurone disease which had been subjected to careful diagnostic scrutiny for another purpose were investigated (Vejjajiva, Foster, and Miller, 1965) . Sera were divided into four or five aliquots for separate testing and stored at -65°C. for not longer than two months before use.
Explants of newborn rat cerebellum were set up on coverslips coated with rat-tail collagen and grown at 350 C. in roller tubes for 18 to 21 days. The nutrient medium comprised Simm's balanced salt solution 40% ; Parker 199 medium (Glaxo) 5%; bovine serum ultrafiltrate (Microbiological Associates, Bethesda, Md) 25% ; human ascitic fluid 25% ; chick embryo extract (nine days in ovo) 5 %. Glucose was added to a final concentration of about 600 mg./100 ml. and pH was maintained within the range 6.9-7.1 by adjustment with CO2 as required.
Cultures were screened in bright field or phase-contrast illumination, and those quite free from degenerative or fatty change were selected for testing purposes.
Tests were carried out in either a Maximow or an opticalglass viewing-chamber (Rosenthal, New York), maintained at 350 C. on a hot stage ; or they were carried out in chambers kept in the incubator and examined at intervals. In this way it was possible to obtain an overall view of the culture and revert to a specific field in order to record the sequence of changes photographically.
In testing each serum the following preparations were set up: (a) culture plus serum under test (25% in nutrient fluid) and (b) culture plus normal human serum (25% in nutrient fluid).
As an additional control, culture plus nutrient fluid alone was set up in many cases. Two preparations of (a) and (b) were set up for each test; occasionally three. Altogether 101 cultures of (a), 63 of (b), and 40 with nutrient fluid alone were set up, so that more than 200 cultures were used in all. Myelotoxicity of serum is known to be complement-dependent (Bornstein, 1963) , and in some early additional experiments fresh guinea-pig serum was added as a source of complement. In these cases additional controls were set up to establish the non-toxicity of the guineapig serum. Later, however, it was found unnecessary to introduce fresh guinea-pig serum, since direct estimation showed adequate complement levels to remain in the stored human sera. At the conclusion of a test the culture was fixed in formolsaline and the axis cylinders were impregnated by the method of Bodian.
Altogether serum was tested from 21 patients in whom the diagnosis of motor neurone disease was based upon the most stringent diagnostic criteria, five in whom the diagnosis was highly probable, and 20 normal subjects. Fig. 5) .
The degenerative changes occurring with, motor neurone disease serum are essentially similar to those brought about by multiple sclerosis serum. The latter are, in general, faster than with motor neurone disease. In addition to myelin beading and fragmentation, a general dissolution of myelin similar to that reported by Bornstein and Appel (1961) commonly took place at the same time, the bright refractile lines seen in the bright field picture gradually becoming narrowed.
Minor changes are sometimes seen when normal serum is subjected to the same testing, and careful assessment of controls is necessary before concluding that any particular serum is toxic. Often these minor changes are temporary and reversible, while true toxic changes are progressive. Serum from two normal subjects did, however, produce well-defined toxic changes (see Table II ). In some cultures which were tested with toxic sera well-defined growths of glial cells were seen on a more superficial plane than the layer of myelinated nerve fibres. The cells, which appeared to be astrocytes (though morphology is an uncertain criterion in assessing the nature of glial cells in vitro), seemed unaffected by the serum, which was so toxic for myelin and its immediately associated (? oligodendroglial) cells (Special Plate, Fig. 6 ).
Examination of Bodian preparations of the cultures which had been exposed to strongly myelotoxic serum (either motor neurone disease or multiple sclerosis) showed persistence of axis cylinders and nerve cells (Special Plate, Fig. 7 ), so that the inimical effect of the serum appeared very largely confined to myelin and the glial cells associated with it.
Discussion
The present work confirms the findings of Bornstein and Appel (1961) and of Bornstein (1963) regarding the toxicity of certain sera for myelinated fibres and glial cells in tissue culture. The pattern of demyelination, beginning with swelling of glial cells and myelin sheaths and progressing to the extrusion of myelin fragments while neurone bodies and axis cylinders are left relatively unaltered, is confirmed. In a later publication Bornstein and Appel (1965) reported demyelinating activity in 9 out of 15 sera from cases of amyotrophic lateral sclerosis. They point out that " the interpretation of tissue culture techniques . . . must be viewed with considerable scepticism in view of the general cytotoxic properties displayed by almost all sera, particularly when applied to short-term or young cultures." All sera in the present study were toxic to myelinassociated glial cells, as judged by their marked swelling followed by disruption in many cases. This was true even with the 25 % serum tested and seemed similar to the toxic effects reported with undiluted serum by Berg and Kallen (1962a, 1962b) . Such effects were therefore regarded as non-specific. Recently Lumsden (1965) has reported nine "strong" positive results, five " weak," and three repeatedly negative out of 17 acute cases of multiple sclerosis, and this, too, confirms the reports summarized by Bornstein and Appel (1965 (Broman, 1947 (Broman, , 1964 and in experimental allergic encephalomyelitis (Barlow, 1956; Vulp6, Hawkins, and Rozdilsky, 1960; Field, 1961) . Finally, the occurrence of two examples of myelotoxicity among our 20 normal sera should be compared with the 2 out of 26 reported by Bornstein and Appel (1965) . Lumsden (1965) does not report upon normals, but in view of the findings of Hashem and Barr (1963) it is possible that normal subjects may -become sensitized to brain or its degeneration products if these are ingested. The possibility exists also that laboratory workers or others habitually exposed to brain might show some antibody responses. In this connexion Field et al. (1963) were able to demonstrate antibody to an encephalitogenic factor in 20.4% of 44 normal subjects. There is, however, no evidence that human antibodies demonstrated by the tanned-cell method parallel serum myelotoxicity.
Summary
Serum from 13 out of 21 undoubted cases of motor neurone disease showed demyelinative activity (at one in four dilution) when allowed to act upon neonatal rat cerebellum cultures. Three out of five other cases in which the diagnosis was open to some doubt also showed this activity. Two out of 20 normal subjects also did so. All sera showed some degree of gliotoxic activity.
Myelotoxicity is not a property possessed exclusively by multiple sclerosis serum, though it may play a part in the pathogenesis of lesions.
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Since the teratogenic potential of the rubella virus was established by Gregg in 1941 a syndrome of maternal rubella in early pregnancy followed by congenital heart disease, cataracts, and deafness in the infant has often been described (Manson et al., 1960; Ingalls et al., 1960; Lundstrdm, 1962) .
Although this classical triad of sequelae to intrauterine rubella infection is well documented, other anomalies have received less attention. Recently, the birth of a large number of American infants with a variety of congenital abnormalities has demonstrated that foetal damage associated with maternal rubella is not confined to a few defects. The damaged infants were born six to nine months after an epidemic of rubella that was widespread in the United States from the end of 1963 to the summer of 1964 (Morbidity and Mortality Weekly Report, 1964; Plotkin, 1964; Phillips et al., 1965) . The congenital abnormalities which followed the epidemic included osseous lesions, hepatosplenomegaly, anaemia, and deficiency of megakaryocytes in the bone-marrow. In addition, retardation of intrauterine growth, neonatal thrombocytopenic purpura, and rubelliform rash were seen with higher frequency than previously reported (Lilndstrdm, 1962; Berge et al., 1963 
